Wide Variation in Clinicians' Assessment of New York Heart Association/World Health Organization Functional Class in Patients With Pulmonary Arterial Hypertension
Authors:
- Darren B. TaichmanDTDarren B. Taichman
- Michael D. McGoonMMMichael D. McGoon
- Michael O. HarhayMHMichael O. Harhay
- Chris Archer-ChickoCAChris Archer-Chicko
- Jeffrey S. SagerJSJeffrey S. Sager
- Meena MurugappanMMMeena Murugappan
- Murali M. ChakinaliMCMurali M. Chakinali
- Harold I. PalevskyHPHarold I. Palevsky
- Robert GallopRGRobert Gallop
- 1 July 2009
- journal article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 84 (7) , 586-592
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- The value of approved therapies for pulmonary arterial hypertensionAmerican Heart Journal, 2007
- A meta-analysis of trials of pulmonary hypertension: A clinical condition looking for drugs and research methodologyAmerican Heart Journal, 2007
- Pulmonary Arterial HypertensionCirculation, 2006
- The New York Heart Association Classes and functional status: What are we really measuring?Heart & Lung, 2006
- Classification and Prognosis of Pulmonary Arterial Hypertension2006
- Diagnosis and differential assessment of pulmonary arterial hypertensionJACC, 2004
- End points and clinical trial designs in pulmonary arterial hypertensionJACC, 2004
- Natural classes of treatment response.Journal of Consulting and Clinical Psychology, 1997
- Natural classes of treatment response.Journal of Consulting and Clinical Psychology, 1997
- Kappa coefficients in epidemiology: An appraisal of a reappraisalJournal of Clinical Epidemiology, 1988